PPIPT00529
Target Protein Information
| Protein_Name | HLA B44 |
|---|---|
| Protein_Sequence | MRVTAPRTLLLLLWGAVALTETWAGSHSMRYFYTAMSRPGRGEPRFITVGYVDDTLFVRFDSDATSPRKEPRAPWIEQEGPEYWDRETQISKTNTQTYRENLRTALRYYNQSEAGSHIIQRMYGCDVGPDGRLLRGYDQDAYDGKDYIALKEDLSSWTAADTAAQITQRKWEAARVAEQDRAYLEGLCVESLRRYLENGKETLQRADPPKTHVTHHPISDHEVTLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWEPSSQSTVPIVGIVAGLAVLAVVVIGAVVAAVMCRRKSS |
| Organism_Source | Homo sapiens |
| Functional_Classification | HLA B44 |
| Cellular_Localization | Plasma membrane |
| Gene_Names | HLA-B |
| UniProt_ID | A9JPE8 |
| Protein-Protein Interaction Networks | |
Peptide Basic Information
| Peptide_Name | SEAAYAKKI |
|---|---|
| Peptide_Sequence | SEAAYAKKI |
| Peptide_Length | 9 |
| Peptide_SMILES | CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CO)C(=O)O |
| Chemical_Modification | None |
| Cyclization_Method | None |
| Linear/Cyclic | Cyclic |
| N-terminal_Modification | Free |
| C-terminal_Modification | Free |
| Amino_Acid_Distribution | |
|
|
|
Peptide Physicochemical
| Molecular_Weight | 980.13 |
|---|---|
| Aliphatic_Index | 76.66667 |
| Aromaticity | 0.11111 |
| Average_Rotatable_Bonds | 3.66667 |
| Charge_at_pH_7 | 0.99832 |
| Isoelectric_point | 9.25605 |
|---|---|
| Hydrogen_Bond_Acceptors | 15 |
| Hydrogen_Bond_Donors | 15 |
| Topological_Polar_Surface_Area | 425.92000 |
| X_logP_energy | -3.55410 |
Interaction Information
| Affinity | IC50=299 nM |
|---|---|
| Affinity_Assay | competition binding assay |
| PDB_ID | None |
| Type | Affinity ligand |
| Structure | |
Reference Information
| Document_Type | Patent |
|---|---|
| Title | HLA BINDING PEPTIDES AND THEIR USES |
| Release_Year | 2006 |
| Patent_ID | US20060079453A1 |